277 related articles for article (PubMed ID: 9223669)
21. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
Cairns P; Shaw ME; Knowles MA
Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
[TBL] [Abstract][Full Text] [Related]
22. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
[TBL] [Abstract][Full Text] [Related]
23. Frequent loss of heterozygosity for markers on chromosome arm 10q in chondrosarcomas.
Raskind WH; Conrad EU; Matsushita M
Genes Chromosomes Cancer; 1996 Jun; 16(2):138-43. PubMed ID: 8818661
[TBL] [Abstract][Full Text] [Related]
24. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.
Nishiyama H; Takahashi T; Kakehi Y; Habuchi T; Knowles MA
Genes Chromosomes Cancer; 1999 Oct; 26(2):171-5. PubMed ID: 10469456
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
Ittmann MM
Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
[TBL] [Abstract][Full Text] [Related]
26. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
Edwards J; Duncan P; Going JJ; Grigor KM; Watters AD; Bartlett JM
Br J Cancer; 2001 Dec; 85(12):1894-9. PubMed ID: 11747332
[TBL] [Abstract][Full Text] [Related]
28. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer.
Simon R; Bürger H; Brinkschmidt C; Böcker W; Hertle L; Terpe HJ
J Pathol; 1998 Aug; 185(4):345-51. PubMed ID: 9828832
[TBL] [Abstract][Full Text] [Related]
29. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.
Paterson RF; Ulbright TM; MacLennan GT; Zhang S; Pan CX; Sweeney CJ; Moore CR; Foster RS; Koch MO; Eble JN; Cheng L
Cancer; 2003 Nov; 98(9):1830-6. PubMed ID: 14584063
[TBL] [Abstract][Full Text] [Related]
31. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.
Yu Y; Yang JL; Markovic B; Jackson P; Yardley G; Barrett J; Russell PJ
Clin Cancer Res; 1997 Jul; 3(7):1045-9. PubMed ID: 9815782
[TBL] [Abstract][Full Text] [Related]
32. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
[TBL] [Abstract][Full Text] [Related]
33. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
[TBL] [Abstract][Full Text] [Related]
34. Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer.
Kim SK; Ro JY; Kemp BL; Lee JS; Kwon TJ; Hong WK; Mao L
Oncogene; 1998 Oct; 17(13):1749-53. PubMed ID: 9796705
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer.
Neville EM; Stewart M; Myskow M; Donnelly RJ; Field JK
Oncogene; 1995 Aug; 11(3):581-5. PubMed ID: 7630642
[TBL] [Abstract][Full Text] [Related]
36. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.
Tsai YC; Nichols PW; Hiti AL; Williams Z; Skinner DG; Jones PA
Cancer Res; 1990 Jan; 50(1):44-7. PubMed ID: 2293558
[TBL] [Abstract][Full Text] [Related]
37. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
[TBL] [Abstract][Full Text] [Related]
38. Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma.
Polascik TJ; Cairns P; Chang WY; Schoenberg MP; Sidransky D
Cancer Res; 1995 Nov; 55(22):5396-9. PubMed ID: 7585608
[TBL] [Abstract][Full Text] [Related]
39. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.
Rasheed BK; McLendon RE; Friedman HS; Friedman AH; Fuchs HE; Bigner DD; Bigner SH
Oncogene; 1995 Jun; 10(11):2243-6. PubMed ID: 7784070
[TBL] [Abstract][Full Text] [Related]
40. Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas.
Balesaria S; Brock C; Bower M; Clark J; Nicholson SK; Lewis P; de Sanctis S; Evans H; Peterson D; Mendoza N; Glaser MG; Newlands ES; Fisher RA
Br J Cancer; 1999 Dec; 81(8):1371-7. PubMed ID: 10604735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
